GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Net Income Including Noncontrolling Interests

Apures Co (XKRX:149300) Net Income Including Noncontrolling Interests : ₩-5,183.4 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Apures Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Apures Co's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was ₩-5,183.4 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-5,183.4 Mil.

Apures Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Apures Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apures Co Net Income Including Noncontrolling Interests Chart

Apures Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,811.48 -11,057.31 -2,754.98 -5,236.80 -5,183.44

Apures Co Semi-Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only -7,811.48 -11,057.31 -2,754.98 -5,236.80 -5,183.44

Apures Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-5,183.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apures Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Apures Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Apures Co (XKRX:149300) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Apures Co Ltd (XKRX:149300) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
XKRX:246250 XKRX:086460 XKRX:303360 XKRX:236340 XKRX:109820 XKRX:229000 XKRX:347740 XKRX:031860 XKRX:221800 XKRX:245620 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
44, Hansan-gil, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR, 17792
Website
http://www.apures.com
Apures Co Ltd is a South Korea based company engaged in the development of transgenic animals to support bio heterogeneous long-term commercialization and new drug efficacy research. It has focused its research capabilities on developing transgenic mini pigs based on gene editing technology and somatic cell nuclear transfer technology.

Apures Co (XKRX:149300) Headlines

No Headlines